Risperidone (4 mg tablets): Supply issue
There is a supply issue affecting Risperidone (Teva) tablets 4 mg presentation.
27 June 2025 | Resupply delayed
There continues to be a supply constraint affecting the 4 mg presentation of Risperidone Teva. Resupply has been delayed.
Risperdal 4 mg may be available. Two x 2 mg risperidone tablets can be taken where the 4 mg tablet is not available.
Affected product
There is a supply issue affecting:
Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
---|---|---|---|---|---|
Risperidone | Risperidone (Teva) | Tab 4 mg | 2466937 | $6.25 | per 60 |
Schedule listing: Risperidone(external link)
Alternative: two x 2 mg tablets
There may be stock of the 4 mg Risperdal alternative available. We are advised that two x 2 mg risperidone tablets can be used as an alternative where a 4 mg is not available.
Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
---|---|---|---|---|---|
Risperidone | Risperdal | Tab 4 mg | 245402 | $6.25 | per 60 |
Medsafe datasheet for Risperdal(external link)
The oral liquid is also available in significant quantities. However, people would need a new prescription.
We listed other brands and strengths to support earlier supply issues affecting risperidone.
- Risperidone Supply issue (Oct 24) A5 flier [PDF 197 KB]
Resupply delayed
We are working with the supplier to understand when the 4 mg Risperidone Teva will be available again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)